Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Roles and functions of HIV-1 Tat protein in the CNS: an overview.

Bagashev A, Sawaya BE.

Virol J. 2013 Dec 21;10:358. doi: 10.1186/1743-422X-10-358. Review.

2.

Non-M variants of human immunodeficiency virus type 1.

Mourez T, Simon F, Plantier JC.

Clin Microbiol Rev. 2013 Jul;26(3):448-61. doi: 10.1128/CMR.00012-13. Review.

3.

Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa.

Caron M, Lekana-Douki SE, Makuwa M, Obiang-Ndong GP, Biba O, Nkoghé D, Kazanji M.

BMC Infect Dis. 2012 Mar 20;12:64. doi: 10.1186/1471-2334-12-64.

4.

What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

Campbell GR, Loret EP.

Retrovirology. 2009 May 25;6:50. doi: 10.1186/1742-4690-6-50. Review.

5.

Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.

Buonaguro L, Tornesello ML, Buonaguro FM.

J Virol. 2007 Oct;81(19):10209-19. Epub 2007 Jul 18. Review. No abstract available.

6.

Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCR.

Plantier JC, Gueudin M, de Oliveira F, Damond F, Lemée V, Brun-Vézinet F, Simon F.

J Clin Microbiol. 2004 Dec;42(12):5866-70.

7.

Timing and reconstruction of the most recent common ancestor of the subtype C clade of human immunodeficiency virus type 1.

Travers SA, Clewley JP, Glynn JR, Fine PE, Crampin AC, Sibande F, Mulawa D, McInerney JO, McCormack GP.

J Virol. 2004 Oct;78(19):10501-6.

8.

Comparison of predicted scaffold-compatible sequence variation in the triple-hairpin structure of human imunodeficiency virus type 1 gp41 with patient data.

Boutonnet N, Janssens W, Boutton C, Verschelde JL, Heyndrickx L, Beirnaert E, van der Groen G, Lasters I.

J Virol. 2002 Aug;76(15):7595-606.

9.

V3 serological subtyping of human immunodeficiency virus type 2 infection is not relevant.

Plantier JC, Damond F, Souquières S, Brun-Vézinet F, Simon F, Barin F.

J Clin Microbiol. 2001 Oct;39(10):3803-7.

Supplemental Content

Support Center